Upstate Active Clinical Trials
Study Title:A Placebo-controlled, Multi-center, Randomized, Phase 2b Study to Evaluate the Efficacy
and Safety of ORMD-0801 in Type 2 Diabetes Mellitus Patients with Inadequate Glycemic Control on Oral
What is the purpose of the study?The purpose of this research study is to test an experimental drug called ORMD-0801, an orally administered formulation of insulin. ORMD-0801 will be referred to as the “study drug” throughout this ICF. An experimental drug is also called an “investigational drug”.
Upstate Institutional Review Board (IRB) Number:1205579
Patient Age Group:Adults
Principal Investigator:Ruth S Weinstock, MD, PhD
Who can I contact for more information?
Name: Suzan M Bzdick, RN